Cytochrome P450 2A6 polymorphism in nasopharyngeal carcinoma

Cancer Letters

Volumn 241, Issue 1, 2006, Pages 135-141

  Tiwawech, Danai ^a,b   Srivatanakul, Petcharin ^a   Karalak, Anant ^a   Ishida, Takafumi ^b  

^a NATIONAL CANCER INSTITUTE   (Thailand)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

CYP2A6; Nasopharyngeal carcinoma; Nitrosamine; Polymorphism

Indexed keywords

COUMARIN 7 HYDROXYLASE; COUMARIN 7-HYDROXYLASE; MIXED FUNCTION OXIDASE; UNSPECIFIC MONOOXYGENASE;

ADULT; AGED; ARTICLE; ENZYMOLOGY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; NASOPHARYNX TUMOR; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ARYL HYDROCARBON HYDROXYLASES; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; NASOPHARYNGEAL NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 39049174661     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.10.026     Document Type: Article

References (42)

1. McDermott A.L., Dutt S.N., Watkinson J.C. The aetiology of nasopharyngeal carcinoma. Clin. Otolaryngol. Allied Sci. 2001, 26:82-90.
2. Cancer Incidence in Five Continents. IARC Scientific Publications No. 143, Lyon 1997, vol. VI:814-815. D.M. Parkin, S.L. Whelan, J.F. Raymond, J. Young (Eds.).
3. S. Deerasamee, N. Martin, S. Sontipong, S. Sriamporn, H. Sriplung, P. Srivatanakul, V. Vatanasapt, D.M. Parkin, J. Ferlay (Eds.), Cancer in Thailand, vol. 2 1992-1994, IARC Technical Report No. 34, Lyon, 1999, pp. 30-32.
4. Shanmugaratnam K., Sobin L.H. The World Health Organization histological classification of tumours upper respiratory tract and ear. A commentary on the second edition. Cancer 1993, 71:2689-2697.
5. AJCC Cancer Staging Manual, fifth ed., Lippincott-Raven, Philadelphia, PA, 1997.
6. Wolf H., zur Hausen H., Becker V. EB virus genomes in epithelial nasopharyngeal carcinoma cells. Nature 1973, 244:245-247.
7. Zheng Y.M., Tuppin P., Hubert A., Jeannel D., Pan Y.J., Zeng Y., et al. Environmental and dietary risk factors for nasopharyngeal carcinoma: a case-control study in Zangwu County, Guangxi, China. Br. J. Cancer 1994, 69:508-514.
8. Lu S.J., Day N.E., Degos L., Lepage V., Wang P.C., Chan S.H., et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature 1990, 346:470-471.
9. Kongruttanachok N., Sukdikul S., Setavarin S., Kerekhjanarong V., Supiyaphun P., Voravud N., et al. Cytochrome P450 2E1 polymorphism and nasopharyngeal carcinoma development in Thailand: a correlative study. BMC Cancer 2001, 1:4-8.
10. Nazar-Stewart V., Vaughan T.L., Burt R.D., Chen C., Berwick M., Swanson G.M. Glutathione S-transferase M1 and susceptibility to nasopharyngeal carcinoma. Cancer Epidemiol. Biomarkers Prev. 1999, 8:547-551.
11. Aoyama T., Yamano S., Guzelian P.S., Gelboin H.V., Gonzalez F.J. Five of 12 forms of vaccinia virus-expressed human cytochrome P450 metabolically activate aflatoxin B1. Proc. Natl Acad. Sci. USA 1990, 87:4790-4793.
12. Crespi C.L., Penman B.W., Leakey J.A., Arlotto M.P., Stark A., Parkinson A., et al. Human cytochrome P450IIA3: cDNA sequence, role of the enzyme in the metabolic activation of promutagens, comparison to nitrosamine activation by human cytochrome P450IIE1. Carcinogenesis 1990, 11:1293-1300.
13. Crespi C.L., Penman B.W., Gelboin H.V., Gonzalez F.J. A tobacco smoke-derived nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, is activated by multiple human cytochrome P450s including the polymorphic cytochrome P4502D6. Carcinogenesis 1991, 12:1197-1201.
14. Yamazaki H., Inui Y., Yun C.H., Guengerich F.P., Shimada T. Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkyl-amines and tobacco-related nitrosoamines in human liver microsomes. Carcinogenesis 1992, 13:1789-1794.
15. Ariyoshi N., Miyamoto M., Umetsu Y., Kunitoh H., Dosaka-Akita H., Sawamura Y., et al. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers. Cancer Epidemiol. Biomarkers Prev. 2002, 11:890-894.
16. Tsukino H., Kuroda Y., Qiu D., Nakao H., Imai H., Katoh T. Effects of cytochrome P-450 (CYP) 2A6 gene deletion and CYP2E1 genotypes on gastric adenocarcinoma. Int. J. Cancer 2002, 100:425-428.
17. Tan W., Chen G.F., Xing D.Y., Song C.Y., Kadlubar F.F., Lin D.X. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population. Int. J. Cancer 2001, 95:96-101.
18. Miyamoto M., Umetsu Y., Dosaka-Akita H., Sawamura Y., Yokota J., Kunitoh H., et al. CYP2A6 gene deletion reduces susceptibility to lung cancer. Biochem. Biophys. Res. Commun. 1999, 261:658-660.
19. Fujieda M., Yamazaki H., Saito T., Kiyotani K., Gyamfi M.A., Sakurai M., et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers. Carcinogenesis 2004, 25:2451-2458.
20. Rautio A., Kraul H., Kojo A., Salmela E., Pelkonen O. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers. Pharmacogenetics 1992, 2:227-233.
21. Yun C.H., Shimada T., Guengerich F.P. Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol. 1991, 40:679-685.
22. Su T., Sheng J.J., Lipinskas T.W., Ding X. Expression of CYP2A genes in rodent and human nasal mucosa. Drug Metab. Dispos. 1996, 24:884-890.
23. Hellmold H., Rylander T., Magnusson M., Reihner E., Warner M., Gustafsson J.A. Characterization of cytochrome P450 enzymes in human breast tissue from reduction mammaplasties. J. Clin. Endocrinol. Metab. 1998, 83:886-895.
24. Crawford E.L., Weaver D.A., DeMuth J.P., Jackson C.M., Khuder S.A., Frampton M.W., et al. Measurement of cytochrome P450 2A6 and 2E1 gene expression in primary human bronchial epithelial cells. Carcinogenesis 1998, 19:1867-1871.
25. Mace K., Bowman E.D., Vautravers P., Shields P.G., Harris C.C., Pfeifer A.M. Characterisation of xenobiotic-metabolising enzyme expression in human bronchial mucosa and peripheral lung tissues. Eur. J. Cancer 1998, 34:914-920.
26. Furukawa M., Nishimura M., Ogino D., Chiba R., Ikai I., Ueda N., et al. Cytochrome P450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci. 2004, 95:520-529.
27. Fernandez-Salguero P., Hoffman S.M., Cholerton S., Mohrenweiser H., Raunio H., Rautio A., et al. A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles. Am. J. Hum. Genet. 1995, 57:651-660.
28. London S.J., Idle J.R., Daly A.K., Coetzee G.A. Genetic variation of CYP2A6, smoking, and risk of cancer. Lancet 1999, 353:898-899.
29. Ariyoshi N., Takahashi Y., Miyamoto M., Umetsu Y., Daigo S., Tateishi T., et al. Structure characterization of a new variant of the CYP2A6 gene (CYP2A6*1B) apparently diagnosed as heterozygotes of CYP2A6*1A and CYP2A6*4C. Pharmacogen etics 2000, 10:687-693.
30. Kamataki T., Nunoya K., Sakai Y., Kushida H., Fujita K. Genetic polymorphism of CYP2A6 in relation to cancer. Mutat. Res. 1999, 428:125-130.
31. Yokoi T., Kamataki T. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese. Pharm. Res. 1998, 15:517-524.
32. Zong Y.S., Sham J.S., Ng M.H., Ou X.T., Guo Y.Q., Zheng S.A., et al. Immunoglobulin a against viral capsid antigen of epstein-barr virus and indirect mirror examination of the nasopharynx in the detection of asymptomatic nasopharyngeal carcinoma. Cancer 1992, 69:3-7.
33. Nam J.M., McLaughlin J.K., Blot W.J. Cigarette smoking, alcohol, and nasopharyngeal carcinoma: a case-control study among US whites. J. Natl Cancer Inst. 1992, 84:619-622.
34. Sriamporn S., Vatanasapt V., Pisani P., Yongchaiyudha S., Rungpitarungsri V. Environmental risk factors for nasopharyngeal carcinoma: a case-control study in north-eastern Thailand. Cancer Epidemiol. Biomarkers Prev. 1992, 1:345-348.
35. IARC, IARC Monographs on the evaluation of carcinogenic risks to humans, Epstein-Barr Virus and Kaposi's Sarcoma Herpesvirus/Human Herpesvirus 8, vol. 70, Lyon, 1997.
36. Armstrong R.W., Imrey P.B., Lye M.S., Armstrong M.J., Yu M.C., Sani S. Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int. J. Cancer 1998, 77:228-235.
37. Ando M., Hamajima N., Ariyoshi N., Kamataki T., Matsuo K., Ohno Y. Association of CYP2A6 gene deletion with cigarette smoking status in Japanese adults. J. Epidemiol. 2003, 13:176-181.
38. Kwon J.T., Nakajima M., Chai S., Yom Y.K., Kim H.K., Yamazaki H., et al. Nicotine metabolism and CYP2A6 allele frequencies in Koreans. Pharmacogenetics 2001, 11:317-323.
39. Oscarson M., McLellan R.A., Gullsten H., Yue Q.Y., Lang M.A., Bernal M.L., et al. Characterization and PCR-based detection of a CYP2A6 gene deletion found at high frequency in a Chinese population. Fed. Eur. Biochem. Soc. Lett. 1999, 448:105-110.
40. Inoue K., Yamazaki H., Shimada T. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians. Arch. Toxicol. 2000, 73:532-539.
41. Loriot M.A., Rebuissou S., Oscarson M., Cenee S., Miyamoto M., Ariyoshi N., et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. Pharmacogenetics 2001, 11:39-44.
42. Hildesheim A., Anderson L.M., Chen C.J., Cheng Y.J., Brinton L.A., Daly A.K., et al. CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan. J. Natl Cancer Inst. 1997, 89:1207-1212.